This inventor holds 5 USPTO granted patents and 3 published patent applications. Top assignees: Temple University, Shifa Biomedical Corporation, Other. Active years: 2015-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Valencia, CA (US) (2015)
- Long Beach, CA (US) (2017)
- Trenton, NJ (US) (2018 - 2024)
Company Filing History:

Years Active: 2015-2024
Title: The Innovative Contributions of Rogelio Martinez
Introduction
Rogelio Martinez is a notable inventor based in Trenton, NJ, who has made significant contributions to the field of pharmaceuticals. With a total of five patents to his name, he has focused on developing innovative solutions for various medical conditions.
Latest Patents
Among his latest patents is the invention of functionalized N,N-dialkylamino phenyl ethers and their method of use. This pharmaceutical composition is designed to treat diseases associated with lysosomal storage dysfunction, including Gaucher's disease. Another significant patent involves anti-PCSK9 compounds and methods for the treatment and prevention of cardiovascular diseases. These compounds, classified as 2-phenylacetamides, are aimed at modulating the action of PCSK9 to reduce LDL-cholesterol levels and combat hypercholesterolemia.
Career Highlights
Rogelio has worked with Temple University, where he has likely contributed to various research initiatives and projects. His work has been instrumental in advancing the understanding and treatment of complex medical conditions.
Collaborations
Throughout his career, Rogelio has collaborated with esteemed colleagues such as Magid A Abou-Gharbia and Wayne Everett Childers. These partnerships have fostered innovation and have been crucial in the development of his patented technologies.
Conclusion
Rogelio Martinez's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to improving healthcare solutions. His work continues to impact the treatment of significant medical conditions, showcasing the importance of innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile